BioLineRx Ltd (BLRX) — Tangible Net Worth Ratio
BioLineRx Ltd (BLRX) has a Tangible Net Worth Ratio of 29.9% as of December 2025. This metric is calculated by deducting intangible assets ($16.37 Million) from net assets ($23.34 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See BioLineRx Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
BioLineRx Ltd Tangible Net Worth Ratio (2008–2025)
This chart shows how BioLineRx Ltd's Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of December 2025, the ratio stands at 29.9%, reflecting net assets of $23.34 Million with intangible assets of $16.37 Million USD. See BioLineRx Ltd (BLRX) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for BioLineRx Ltd (2008–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for BioLineRx Ltd from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see BLRX company net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 29.9% | $23.34 Million | $16.37 Million | $40.90 Million | ▲ +7.5 pp |
| 2024 | 22.4% | $13.46 Million | $10.45 Million | $38.91 Million | ▲ +34.7 pp |
| 2023 | -12.3% | $13.22 Million | $14.85 Million | $63.92 Million | ▼ -69.3 pp |
| 2022 | 57.0% | $50.84 Million | $21.89 Million | $76.38 Million | ▼ -11.2 pp |
| 2021 | 68.1% | $68.09 Million | $21.70 Million | $81.39 Million | ▲ +66.7 pp |
| 2020 | 1.4% | $22.03 Million | $21.71 Million | $47.29 Million | ▼ -33.0 pp |
| 2019 | 34.4% | $33.38 Million | $21.89 Million | $53.57 Million | ▼ -12.4 pp |
| 2018 | 46.8% | $41.32 Million | $21.97 Million | $56.23 Million | ▼ -39.9 pp |
| 2017 | 86.7% | $52.88 Million | $7.02 Million | $60.97 Million | ▼ -12.8 pp |
| 2016 | 99.5% | $35.03 Million | $181.00K | $38.94 Million | ▼ -0.2 pp |
| 2015 | 99.7% | $47.61 Million | $152.00K | $51.30 Million | ▲ +0.1 pp |
| 2014 | 99.6% | $31.77 Million | $117.36K | $36.17 Million | ▲ +1.8 pp |
| 2013 | 97.8% | $11.68 Million | $252.12K | $19.95 Million | ▼ -0.3 pp |
| 2012 | 98.1% | $14.97 Million | $284.53K | $24.31 Million | ▼ -0.6 pp |
| 2011 | 98.7% | $22.53 Million | $300.58K | $29.34 Million | ▼ -0.3 pp |
| 2010 | 99.0% | $37.26 Million | $381.76K | $43.66 Million | ▲ +1.6 pp |
| 2009 | 97.4% | $31.13 Million | $803.06K | $42.02 Million | ▲ +1.5 pp |
| 2008 | 95.9% | $20.75 Million | $848.56K | $30.64 Million | — |